Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Ludwig Institute for Cancer Research
- License Information
-
More Information
Article History
Received: 25 July 2024
Accepted: 22 September 2024
First Online: 14 October 2024
Competing interests
: YK holds equity interest in KayoThera and Firebrand therapeutics.
